These success, together with a preceding report exhibiting that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like habits in mice,2 aid the notion of focusing on ACKR3 as a unique way to modulate the opioid method, which could open new therapeutic avenues for opioid-associated disorders.Gene expression Investigation uncovered that ACKR3